Latest AstraZeneca Pharma stock price

AstraZeneca Pharma P/E Ratio

ASTRAZEN • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
108.76
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 108.76
Current Price ₹8760.00
EPS (TTM) ₹46.30
Exchange NSE

Valuation Signal

Signal Overvalued

Sector Context

Sector Average 48.93
Sector Median 25.71
Sector Rank #11 of 139
Sector Percentile 7.9%

Key P/E Ratio Insights for AstraZeneca Pharma

  • Stock appears overvalued with PE of 108.76, suggesting caution for new investments
  • Trading at premium to sector average PE of 48.93

View the ASTRAZEN equity price for detailed stock performance.

Sector P/E Ratio Comparison

Comparing AstraZeneca Pharma with other companies in Healthcare sector
Sector Average
48.93
Sector Median
25.71
Lowest P/E
0.97
Highest P/E
993.26
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.97 ₹36 Low
Murae Organisor MURAE 3.0 ₹43 Low
Ind Swift Laboratories INDSWFTLAB 4.67 ₹1,166 Low
Amwill Health Care AMWILL 6.5 ₹67 Low
Medicamen Organics MEDIORG 6.94 ₹27 Low
Galaxy Medicare GML 7.25 ₹24 Low
Unichem Laboratories UNICHEMLAB 7.74 ₹2,188 Low
Zenith Drugs ZENITHDRUG 7.9 ₹76 Low
Brooks Laboratories BROOKS 8.01 ₹184 Low
Vasundhara Rasayans VRL 9.97 ₹37 Low